|
1
|
Sempoux C, Jibara G, Ward SC, Fan C, Qin
L, Roayaie S, Fiel MI, Schwartz M and Thung SN: Intrahepatic
cholangiocarcinoma: New insights in pathology. Semin Liver Dis.
31:49–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang J, Xie H, Ling Q, Lu D, Lv Z, Zhuang
R, Liu Z, Wei X, Zhou L, Xu X and Zheng S: Coding-noncoding gene
expression in intrahepatic cholangiocarcinoma. Transl Res.
168:107–121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Andersen JB: Molecular pathogenesis of
intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci.
22:101–113. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deng G, Zhu L, Huang F, Nie W, Huang W, Xu
H, Zheng S, Yi Z and Wan T: SALL4 is a novel therapeutic target in
intrahepatic cholangiocarcinoma. Oncotarget. 6:27416–27426. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng Z, Liu C and Wu M: New insights into
long noncoding RNAs and their roles in glioma. Mol Cancer.
17:612018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smolle MA and Pichler M: The role of long
non-coding RNAs in osteosarcoma. Noncoding RNA. 4(pii):
E72018.PubMed/NCBI
|
|
7
|
Xu S, Kong D, Chen Q, Ping Y and Pang D:
Oncogenic long noncoding RNA landscape in breast cancer. Mol
Cancer. 16:1292017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ruan X: Long noncoding RNA central of
glucose homeostasis. J Cell Biochem. 117:1061–1065. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Taylor DH, Chu ET, Spektor R and Soloway
PD: Long non-coding RNA regulation of reproduction and development.
Mol Reprod Dev. 82:932–956. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia XL, Xue D, Xiang TH, Xu HY, Song DK,
Cheng PG and Wang JQ: Overexpression of long non-coding RNA CRNDE
facilitates epithelial-mesenchymal transition and correlates with
poor prognosis in intrahepatic cholangiocarcinoma. Oncol Lett.
15:4105–4112. 2018.PubMed/NCBI
|
|
12
|
Zhang S, Xiao J, Chai Y, Du YY, Liu Z,
Huang K, Zhou X and Zhou W: LncRNA-CCAT1 promotes migration,
invasion, and EMT in intrahepatic cholangiocarcinoma through
suppressing miR-152. Dig Dis Sci. 62:3050–3058. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lv L, Wei M, Lin P, Chen Z, Gong P, Quan Z
and Tang Z: Integrated mRNA and lncRNA expression profiling for
exploring metastatic biomarkers of human intrahepatic
cholangiocarcinoma. Am J Cancer Res. 7:688–699. 2017.PubMed/NCBI
|
|
14
|
Wei Y, Sun Q, Zhao L, Wu J, Chen X, Wang
Y, Zang W and Zhao G: LncRNA UCA1-miR-507-FOXM1 axis is involved in
cell proliferation, invasion and G0/G1 cell cycle arrest in
melanoma. Med Oncol. 33:882016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu
Y, Feng Y, Liu H, Fei B, Mao Y, et al: LncRNA-UCA1 enhances cell
proliferation and 5-fluorouracil resistance in colorectal cancer by
inhibiting miR-204-5p. Sci Rep. 6:238922016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang HM, Lu JH, Chen WY and Gu AQ:
Upregulated lncRNA-UCA1 contributes to progression of lung cancer
and is closely related to clinical diagnosis as a predictive
biomarker in plasma. Int J Clin Exp Med. 8:11824–11830.
2015.PubMed/NCBI
|
|
17
|
Zhou Y, Chen Y, Ding W, Hua Z, Wang L, Zhu
Y, Qian H and Dai T: LncRNA UCA1 impacts cell proliferation,
invasion, and migration of pancreatic cancer through regulating
miR-96/FOXO3. IUBMB Life. 70:276–290. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo J, Chen J, Li H, Yang Y, Yun H, Yang S
and Mao X: LncRNA UCA1 promotes the invasion and EMT of bladder
cancer cells by regulating the miR-143/HMGB1 pathway. Oncol Lett.
14:5556–5562. 2017.PubMed/NCBI
|
|
19
|
Xue M, Pang H, Li X, Li H, Pan J and Chen
W: Long non-coding RNA urothelial cancer-associated 1 promotes
bladder cancer cell migration and invasion by way of the
hsa-miR-145-ZEB1/2-FSCN1 pathway. Cancer Sci. 107:18–27. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fang Z, Zhao J, Xie W, Sun Q, Wang H and
Qiao B: LncRNA UCA1 promotes proliferation and cisplatin resistance
of oral squamous cell carcinoma by sunppressing miR-184 expression.
Cancer Med. 6:2897–2908. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu Y, Yao Y, Leng K, Li Z, Qin W, Zhong X,
Kang P, Wan M, Jiang X and Cui Y: Long non-coding RNA UCA1
indicates an unfavorable prognosis and promotes tumorigenesis via
regulating AKT/GSK-3β signaling pathway in cholangiocarcinoma.
Oncotarget. 8:96203–96214. 2017.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma SL, Li AJ, Hu ZY, Shang FS and Wu MC:
Co-expression of the carbamoyl-phosphate synthase 1 gene and its
long non-coding RNA correlates with poor prognosis of patients with
intrahepatic cholangiocarcinoma. Mol Med Rep. 12:7915–7926. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeng B, Ye H, Chen J, Cheng D, Cai C, Chen
G, Chen X, Xin H, Tang C and Zeng J: LncRNA TUG1 sponges miR-145 to
promote cancer progression and regulate glutamine metabolism via
Sirt3/GDH axis. Oncotarget. 8:113650–113661. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karakatsanis A, Papaconstantinou I,
Gazouli M, Lyberopoulou A, Polymeneas G and Voros D: Expression of
microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c,
miR-221, miR-222, and miR-223 in patients with hepatocellular
carcinoma or intrahepatic cholangiocarcinoma and its prognostic
significance. Mol Carcinog. 52:297–303. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sun Y, Jin JG, Mi WY, Zhang SR, Meng Q and
Zhang ST: Long noncoding RNA UCA1 targets miR-122 to promote
proliferation, migration, and invasion of glioma cells. Oncol Res.
26:103–110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou Y, Meng X, Chen S, Li W, Li D, Singer
R and Gu W: IMP1 regulates UCA1-mediated cell invasion through
facilitating UCA1 decay and decreasing the sponge effect of UCA1
for miR-122-5p. Breast Cancer Res. 20:322018. View Article : Google Scholar : PubMed/NCBI
|
